Abstract

As attitudes toward cannabis, its legal status, and patterns of use continue to evolve, the landscape surrounding this substance is in a constant state of flux. Against this backdrop, this review aims to provide an up-to-date overview of the literature on the comorbidity of cannabis use and cannabis use disorder (CUD) with other substance use and psychiatric disorders.

Results: 

• A strong body of literature shows associations between cannabis use and CUD with other drug use, psychosis, mood disorders, anxiety disorders, and personality disorders.
• The strongest evidence of a...

Introduction 

There is increasing interest and evidence for the use of cannabinoid medications in the treatment of cannabis use disorder, but little examination of the correlates of successful treatment. This paper is a secondary analysis of a randomised placebo-controlled trial of nabiximols for the treatment of cannabis use disorder (CUD), aiming to identify which client and treatment characteristics impact treatment engagement and outcomes.

Method

Bayesian multiple regression models were used to examine the impact of age, gender, duration of regular cannabis use, daily quantity of...

Introduzione e obiettivi

C'è un crescente interesse e prove per l'uso di farmaci cannabinoidi nel trattamento del disturbo da uso di cannabis, ma poco esame dei correlati del trattamento di successo. Questo documento è un'analisi secondaria di uno studio randomizzato controllato con placebo di nabiximols per il trattamento del disturbo da uso di cannabis (CUD), con l'obiettivo di identificare quali caratteristiche del cliente e del trattamento influenzano l'impegno e gli esiti del trattamento.

Metodo

Sono stati utilizzati modelli bayesiani di regressione multipla per esaminare l'impatto di...